Tuberous sclerosis complex (TSC) is a rare genetic condition that causes non-cancerous growths, known as tubers, to develop in different organs of the body, including the brain. When these growths affect brain activity, they can trigger frequent seizures, which may begin in early childhood and continue throughout life. Seizures associated with tuberous sclerosis can vary in severity and may interfere with development, learning, and daily functioning.
LeafEase supports individuals experiencing seizures linked to tuberous sclerosis in exploring regulated medical cannabis treatment when symptoms remain difficult to manage through conventional care.
of individuals with tuberous sclerosis develop epilepsy during their lifetime.
people are estimated to live with tuberous sclerosis complex worldwide, including patients in the UK.
Up to 60% of seizures in tuberous sclerosis begin during the first year of life
Seizures are one of the most common neurological symptoms of tuberous sclerosis and may occur in different forms.
If these symptoms sound familiar and continue despite usual treatments, you can quickly check your eligibility for medical cannabis treatment through LeafEase’s simple online assessment.
In the UK, treatment for seizures linked to tuberous sclerosis usually focuses on controlling seizure activity and supporting neurological development. Individuals may receive specialist neurological care along with supportive therapies aimed at improving safety and quality of life.
For some individuals, seizures may continue despite these approaches. When symptoms remain difficult to manage with conventional care, medical cannabis may offer an alternative option under specialist supervision.
At LeafEase, patients undergo a detailed clinical assessment to determine treatment suitability and receive ongoing monitoring to support safe and effective seizure management.
Tuberous sclerosis complex is caused by genetic mutations affecting the TSC1 or TSC2 genes, which normally help regulate cell growth. When these genes do not function properly, abnormal growth may develop in different organs, including the brain.
These factors and brain lesions can disrupt normal electrical activity and brain functioning, leading to seizures in individuals with TSC.
Find out if you may be eligible for Tuberous Sclerosis-Related Seizures medical cannabis treatment here.
Medical cannabis interacts with the body’s endocannabinoid system, which helps regulate neurological activity and brain signalling. The cannabinoids CBD (cannabidiol) and THC (tetrahydrocannabinol) influence pathways involved in seizure control.
CBD has been studied for its ability to reduce seizure frequency in certain epilepsy conditions, while THC may influence neurological signalling and sleep regulation. In the UK, specialist clinicians prescribe and monitor medical cannabis treatment to ensure safety and effectiveness.
Studies on Medical Cannabis as an Alternative Treatment for Tuberous Sclerosis-Related Seizures
https://pubmed.ncbi.nlm.nih.gov/35151190/
https://jamanetwork.com/journals/jamaneurology/fullarticle/2774314
At LeafEase, treatment is delivered under specialist supervision, ensuring every patient is safely assessed and supported throughout their care. Our personalised approach helps you explore medical cannabis as a regulated, clinically guided option for long-term pain relief.
Medical cannabis treatment is generally well tolerated when used under specialist supervision. Some individuals may experience mild effects as their body adjusts to treatment.
These effects are usually mild and may improve as treatment is adjusted. Regular clinical reviews help ensure treatment remains safe and suitable.
Find out whether medical cannabis may be a suitable treatment option for Tuberous Sclerosis-Related Seizures
Simply submit your questions, and we’ll do our best to address them promptly and thoroughly. Your health is our priority, and we’re here to support you every step of the way.
Medical cannabis, particularly CBD-based treatments, has been studied for its potential to reduce seizure frequency in individuals with tuberous sclerosis complex.
Specialist clinicians in the UK may prescribe cannabis-based treatments for severe epilepsy conditions when conventional therapies have not provided sufficient seizure control.
CBD has been studied for its ability to influence brain signalling involved in seizure activity, while THC may contribute to regulating neurological activity and improving sleep patterns.
Medical cannabis may help manage symptoms such as frequent seizures, sleep disturbance, and neurological discomfort linked to tuberous sclerosis.
At LeafEase, patients undergo a specialist clinical assessment where symptoms, medical history, and previous treatments are reviewed to determine whether regulated medical cannabis treatment may be appropriate.
